Literature DB >> 25601533

Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure.

Grace E Boynton1, Maxwell S Stem1, Leon Kwark2, Gregory R Jackson3, Sina Farsiu4, Thomas W Gardner5.   

Abstract

PURPOSE: To identify changes in retinal function and structure in persons with proliferative diabetic retinopathy (PDR), including the effects of panretinal photocoagulation (PRP).
DESIGN: Cross-sectional study. PARTICIPANTS: Thirty adults who underwent PRP for PDR, 15 adults with untreated PDR, and 15 age-matched controls.
METHODS: Contrast sensitivity, frequency doubling perimetry (FDP), Humphrey visual fields, photostress recovery, and dark adaptation were assessed. Fundus photography and macular spectral-domain optical coherence tomography (SD OCT) were performed. To quantify retinal layer thicknesses, SD OCT scans were segmented semiautomatically. MAIN OUTCOME MEASURES: Visual function measures were compared among patients with PDR and PRP, untreated patients with PDR, and controls. Mean retinal layer thicknesses were compared between groups. Correlation analyses were performed to evaluate associations between visual function measures and retinal layer thicknesses.
RESULTS: A significant reduction of FDP mean deviation (MD) was exhibited in PRP-treated patients with PDR (MD ± standard deviation, -8.20±5.76 dB; P < 0.0001) and untreated patients (-5.48±4.48 dB; P < 0.0001) relative to controls (1.07±2.50 dB). Reduced log contrast sensitivity compared with controls (1.80±0.14) also was observed in both PRP-treated patients (1.42±0.17; P < 0.0001) and untreated patients (1.56±0.20; P = 0.001) with PDR. Compared with controls, patients treated with PRP demonstrated increased photostress recovery time (151.02±104.43 vs. 70.64±47.14 seconds; P = 0.001) and dark adaptation speed (12.80±5.15 vs. 9.74±2.56 minutes; P = 0.022). Patients who underwent PRP had diffusely thickened nerve fiber layers (P = 0.024) and diffusely thinned retinal pigment epithelium (RPE) layers (P = 0.009) versus controls. Untreated patients with PDR also had diffusely thinned RPE layers (P = 0.031) compared with controls.
CONCLUSIONS: Patients with untreated PDR exhibited inner retinal dysfunction, as evidenced by reduced contrast sensitivity and FDP performance, accompanied by alterations in inner and outer retinal structure. Patients who underwent PRP had more profound changes in outer retinal structure and function. Distinguishing the effects of PDR and PRP may guide the development of restorative vision therapies for patients with advanced diabetic retinopathy.
Copyright © 2015 American Academy of Ophthalmology. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25601533      PMCID: PMC4414692          DOI: 10.1016/j.ophtha.2014.12.001

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  51 in total

1.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

2.  Visual field loss after argon laser panretinal photocoagulation in diabetic retinopathy: full- versus mild-scatter coagulation.

Authors:  D Pahor
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

3.  Long-term temporal changes of peripapillary retinal nerve fiber layer thickness before and after panretinal photocoagulation in severe diabetic retinopathy.

Authors:  Jongshin Kim; Se Joon Woo; Jeeyun Ahn; Ki Ho Park; Hum Chung; Kyu Hyung Park
Journal:  Retina       Date:  2012 Nov-Dec       Impact factor: 4.256

4.  Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics.

Authors:  S A Vinores; C Gadegbeku; P A Campochiaro; W R Green
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

5.  The longitudinal changes of retinal nerve fiber layer thickness after panretinal photocoagulation in diabetic retinopathy patients.

Authors:  Sung B Lee; Joo Y Kwag; Haeng J Lee; Young J Jo; Jung Y Kim
Journal:  Retina       Date:  2013-01       Impact factor: 4.256

6.  Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.

Authors:  A J Barber; D A Antonetti; T W Gardner
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-10       Impact factor: 4.799

7.  An alternative pathway mediates the mouse and human cone visual cycle.

Authors:  Jin-Shan Wang; Vladimir J Kefalov
Journal:  Curr Biol       Date:  2009-09-24       Impact factor: 10.834

8.  Relationship between contrast sensitivity and metabolic control in diabetics with and without retinopathy.

Authors:  A Verrotti; L Lobefalo; M T Petitti; L Mastropasqua; G Morgese; F Chiarelli; P E Gallenga
Journal:  Ann Med       Date:  1998-08       Impact factor: 4.709

9.  Xenon arc and argon laser photocoagulation in the treatment of diabetic disc neovascularization. Part 2. Effect on colour vision.

Authors:  J Birch; A M Hamilton
Journal:  Trans Ophthalmol Soc U K       Date:  1981

10.  Thickness of receptor and post-receptor retinal layers in patients with retinitis pigmentosa measured with frequency-domain optical coherence tomography.

Authors:  Donald C Hood; Christine E Lin; Margot A Lazow; Kirsten G Locke; Xian Zhang; David G Birch
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-14       Impact factor: 4.799

View more
  29 in total

1.  Diabetic retinal pigment epitheliopathy: fundus autofluorescence and spectral-domain optical coherence tomography findings.

Authors:  Eui Chun Kang; Yuri Seo; Suk Ho Byeon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-06       Impact factor: 3.117

2.  Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration.

Authors:  Sheldon Rowan; Shuhong Jiang; Tal Korem; Jedrzej Szymanski; Min-Lee Chang; Jason Szelog; Christa Cassalman; Kalavathi Dasuri; Christina McGuire; Ryoji Nagai; Xue-Liang Du; Michael Brownlee; Naila Rabbani; Paul J Thornalley; James D Baleja; Amy A Deik; Kerry A Pierce; Justin M Scott; Clary B Clish; Donald E Smith; Adina Weinberger; Tali Avnit-Sagi; Maya Lotan-Pompan; Eran Segal; Allen Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-15       Impact factor: 11.205

3.  PANRETINAL PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Comparison of Peripapillary Retinal Nerve Fiber Layer Thickness in a Randomized Clinical Trial.

Authors:  Lee M Jampol; Isoken Odia; Adam R Glassman; Carl W Baker; Anjali M Bhorade; Dennis P Han; Glenn J Jaffe; Michele Melia; Neil M Bressler; Angelo P Tanna
Journal:  Retina       Date:  2019-01       Impact factor: 4.256

Review 4.  Retinal oxygen: from animals to humans.

Authors:  Robert A Linsenmeier; Hao F Zhang
Journal:  Prog Retin Eye Res       Date:  2017-01-18       Impact factor: 21.198

5.  Antiangiogenic activity of PLGA-Lupeol implants for potential intravitreal applications.

Authors:  Daniel Crístian Ferreira Soares; Diogo Coelho de Paula Oliveira; Luciola Silva Barcelos; Alan Sales Barbosa; Lorena Carla Vieira; Danyelle M Townsend; Domenico Rubello; André Luis Branco de Barros; Lucienir Pains Duarte; Armando Silva-Cunha
Journal:  Biomed Pharmacother       Date:  2017-05-27       Impact factor: 6.529

6.  Effect of miR-200b on retinal endothelial cell function under high glucose environment.

Authors:  Qun Jiang; Fei Zhao; Xinmin Liu; Rongrong Li; Jianming Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

7.  Beyond Performance Metrics: Automatic Deep Learning Retinal OCT Analysis Reproduces Clinical Trial Outcome.

Authors:  Jessica Loo; Traci E Clemons; Emily Y Chew; Martin Friedlander; Glenn J Jaffe; Sina Farsiu
Journal:  Ophthalmology       Date:  2019-12-23       Impact factor: 12.079

8.  Glucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus.

Authors:  M S Stem; G E Dunbar; G R Jackson; S Farsiu; R Pop-Busui; T W Gardner
Journal:  Eye (Lond)       Date:  2016-04-01       Impact factor: 3.775

Review 9.  New Therapeutic Approaches in Diabetic Retinopathy.

Authors:  Kamyar Vaziri; Stephen G Schwartz; Nidhi Relhan; Krishna S Kishor; Harry W Flynn
Journal:  Rev Diabet Stud       Date:  2015-08-10

10.  Loss of CD40 attenuates experimental diabetes-induced retinal inflammation but does not protect mice from electroretinogram defects.

Authors:  Ivy S Samuels; Jose-Andres C Portillo; Yanling Miao; Timothy S Kern; Carlos S Subauste
Journal:  Vis Neurosci       Date:  2017-01       Impact factor: 3.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.